
‘Targeting optimal care, together’ is the theme of ESTRO 38. It is a way to underline the multiprofessional and multidisciplinary aspect of this specialty. The interdisciplinary component of the scientific programme includes sessions on a wide range of topics: Artificial Intelligence in radiation oncology: role and potential, Radio-immunotherapy, MR machines and treatment adaptation, Clinical trials for particle therapy, DNA damage response with radiotherapy, Radiotherapy biomarkers: a confluence of imaging, genetics and pathology as well as Predictive models of toxicity and big data and many other topics that trace the path to Precision Medicine.
‘Targeting optimal care, together’ is the theme of ESTRO 38. It is a way to underline the multiprofessional and multidisciplinary aspect of this specialty. The interdisciplinary component of the scientific programme includes sessions on a wide range of topics: Artificial Intelligence in radiation oncology: role and potential, Radio-immunotherapy, MR machines and treatment adaptation, Clinical trials for particle therapy, DNA damage response with radiotherapy, Radiotherapy biomarkers: a confluence of imaging, genetics and pathology as well as Predictive models of toxicity and big data and many other topics that trace the path to Precision Medicine.
interviews


La radioterapia oncologica nella visione strategica di ESTRO


Efficacy of the “Watch and wait” approach to rectal cancer


"Contact radiation" therapy to fight early rectal tumors


Papillon Technique in the evolution of rectal cancer care


Interprofessional aspects of practicing radiation oncology


UICC, global advocacy to improve cancer control


Stem cell sparing IMRT for head and neck cancer patients


Treatment sequencing in oligometastatic prostate cancer


A new trial on treating patients with single metastases


Volumi di trattamento per recidiva linfonodale pelvica


Radiotherapy vs oncoimmunology: molecular interactions


Combining radiation therapy with immunomodulation


Normal tissue effects of radiotherapy


Prostate cancer: focal salvage high-dose-rate brachytherapy

